We must emphasize that ERCP findings of choledocolithiasis and biliopancreatic tumors did not show statistically significant differences between the groups. Papillary carcinomas appeared in 5.6% of both groups, and there were also no significant differences between the two groups in terms of patients with cholangiocarcinomas and pancreatic cancer. From the first descriptions the ERCP has evolved in an extraordinary way.
Debe resaltarse que los hallazgos en la CPRE de coledocolitiasis o de tumores biliopancreáticos no mostraron diferencias estadísticamente significativas, los carcinomas de la papila se presentaron en el 5,6% de los dos grupos de pacientes; tampoco hubo diferencias significativamente estadísticas entre los pacientes con colangiocarcinomas y los tumores de páncreas.